Additionally, TGF-β was a prominent anti-inflammatory cytokine that was dramatically decreased in T2DM mice compared to the control mice, while surfactin treatment significantly increased its levels; this trend was similar to the control mice. The gene discussed is TGFB1; the disease is type 2 diabetes mellitus.